Estrogen Effects [fndg]
therapy [ftcn]
Vasoactive [qlco]
postmenopausal [tmco]
Health [idcn]
Women [popg]
Evaluate [ftcn]
ROUTE [ftcn]
estrogen therapy [topp]
Affect [menp]
Levels [qlco]
Vasoactive [qlco]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Methods [inpr]
Conduct [inbe]
Cross-Over Study [resa]
Health [idcn]
Women [popg]
Women [popg]
Received [qlco]
Oral [spco]
estrogen therapy [topp]
O NOS [inpr]
estrogen therapy [topp]
mg% [qnco]
Oral [spco]
17 beta-Estradiol [horm, phsu, strd]
Daily [tmco]
transdermal estrogen [horm, phsu, strd]
therapy [ftcn]
Regimen [topp]
estrogen therapy [topp]
Beta [plnt]
Estradiol 1.5 MG [clnd]
Gel [bodm]
Daily [tmco]
Wash [acty]
Out [spco]
Interval [tmco]
Blood Pressure [orgf]
Plasma [bdsu]
Endothelin-1 [aapp, bacs]
estrogen therapy [topp]
Prostacyclin [bacs, eico, phsu]
Metabolite [bacs]
Nitrite [chvs]
Nitrate [chvs]
Epinephrine [horm, nsba, orch, phsu]
Norepinephrine [nsba, orch, phsu]
Lipid [lipd]
Profile [lbpr]
Measured [qlco]
baseline [bodm]
treatment [ftcn]
regimens [inpr]
Reduced [qlco]
Epinephrine [horm, nsba, orch, phsu]
P NOS [aapp, imft]
Norepinephrine [nsba, orch, phsu]
Levels [qlco]
P NOS [aapp, imft]
O NOS [inpr]
estrogen therapy [topp]
Reduced [qlco]
Low-Density Lipoproteins [aapp, bacs, lipd]
P NOS [aapp, imft]
Increased [qnco]
Values [qlco]
P NOS [aapp, imft]
Regimen [topp]
estrogen therapy [topp]
Conclusions [idcn]
Obtained [ftcn]
Health [idcn]
Women [popg]
Menopause [phsf]
Ratio [qnco]
Vasodilator [phsu]
Prostacyclin [bacs, eico, phsu]
Vasoconstrictor [phsu]
estrogen therapy [topp]
Bioavailability [qnco]
shifted [ftcn]
Previous [tmco]
O NOS [inpr]
estrogen therapy [topp]
Unchanged [fndg]
estrogen therapy [topp]
catecholamines levels [lbtr]
Reduced [qlco]
Treatments [topp]
therapy [ftcn]
Represent [acty]
Very [qlco]
effects [qlco]
Evoked [qlco]
estrogen therapy [topp]
Cardiovascular system [bdsy]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
